Constitutive secretion of tau protein by an unconventional mechanism

被引:177
作者
Chai, Xiyun [1 ]
Dage, Jeffrey L. [1 ]
Citron, Martin
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
Tau protein; Unconventional secretion; Alzheimer's disease; Neurodegeneration; PLURIPOTENT STEM-CELLS; AMYLOID PRECURSOR PROTEIN; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; MOUSE MODEL; NEUROFIBRILLARY TANGLES; PASSIVE-IMMUNIZATION; BETA-PEPTIDE; PHOSPHO-TAU; PATHOLOGY;
D O I
10.1016/j.nbd.2012.05.021
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The microtubule-associated protein tau plays a critical role in the pathogenesis of Alzheimer's disease and several related disorders. In the disease tau aggregates into paired helical and straight filaments, which can form higher order neurofibrillary tangles in neurons and this pathology is associated with progressive neuronal loss and cognitive decline. Tau is a cytoplasmic protein and is thought to be released only from degenerating cells. In contrast, here we provide evidence that tau is constitutively secreted at a low level. We directly show tau release in cell culture model systems. In inducible transfected cell lines we observe that a small proportion of full-length tau is released from intact cells in a time dependent manner. We show that this tau is released by an unconventional secretion process, as the release is temperature dependent but not blocked by inhibitors of the conventional secretory pathway. We characterize the released tau as full length, not vesicle associated and containing Phospho-Tau (181P) proportional to its intracellular concentration. We demonstrate that tau secretion and its suppression by low temperature also occurs in human neurons differentiated from induced pluripotent stem cells. The constitutive tau secretion that we propose provides the most parsimonious explanation for the observed presence of tau in the CSF of healthy animals and human beings. If previously postulated pathogenic extracellular tau intermediates are released by this route, low level constitutive tau secretion could play a role in the spread of tau pathology in Alzheimer's disease and other human tauopathies. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:356 / 366
页数:11
相关论文
共 49 条
[1]   Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms [J].
Andorfer, C ;
Kress, Y ;
Espinoza, M ;
de Silva, R ;
Tucker, KL ;
Barde, YA ;
Duff, K ;
Davies, P .
JOURNAL OF NEUROCHEMISTRY, 2003, 86 (03) :582-590
[2]   Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment [J].
Andreasen, N ;
Vanmechelen, E ;
Vanderstichele, H ;
Davidsson, P ;
Blennow, K .
ACTA NEUROLOGICA SCANDINAVICA, 2003, 107 :47-51
[3]   Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements [J].
Asuni, Ayodeji A. ;
Boutajangout, Allal ;
Quartermain, David ;
Sigurdsson, Einar M. .
JOURNAL OF NEUROSCIENCE, 2007, 27 (34) :9115-9129
[4]   Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias [J].
Barghorn, S ;
Zheng-Fischhöfer, Q ;
Ackmann, M ;
Biernat, J ;
von Bergen, M ;
Mandelkow, EM ;
Mandelkow, E .
BIOCHEMISTRY, 2000, 39 (38) :11714-11721
[5]   Tau Transgenic Mice as Models for Cerebrospinal Fluid Tau Biomarkers [J].
Barten, Donna M. ;
Cadelina, Gregory W. ;
Hoque, Nina ;
DeCarr, Lynn B. ;
Guss, Valerie L. ;
Yang, Ling ;
Sankaranarayanan, Sethu ;
Wes, Paul D. ;
Flynn, Marianne E. ;
Meredith, Jere E. ;
Ahlijanian, Michael K. ;
Albright, Charles F. .
JOURNAL OF ALZHEIMERS DISEASE, 2011, 24 :127-141
[6]   Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice [J].
Boimel, Moran ;
Grigoriadis, Nikolaos ;
Lourbopoulos, Athanasios ;
Haber, Esther ;
Abramsky, Oded ;
Rosenmann, Hanna .
EXPERIMENTAL NEUROLOGY, 2010, 224 (02) :472-485
[7]   Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain [J].
Boutajangout, Allal ;
Ingadottir, Johanna ;
Davies, Peter ;
Sigurdsson, Einar M. .
JOURNAL OF NEUROCHEMISTRY, 2011, 118 (04) :658-667
[8]  
BRAMBLETT GT, 1992, LAB INVEST, V66, P212
[9]   Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models REDUCTION OF TAU PATHOLOGY AND DELAY OF DISEASE PROGRESSION [J].
Chai, Xiyun ;
Wu, Su ;
Murray, Tracey K. ;
Kinley, Robert ;
Cella, Claire V. ;
Sims, Helen ;
Buckner, Nicola ;
Hanmer, Jenna ;
Davies, Peter ;
O'Neill, Michael J. ;
Hutton, Michael L. ;
Citron, Martin .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (39) :34457-34467
[10]   MUTATION OF THE BETA-AMYLOID PRECURSOR PROTEIN IN FAMILIAL ALZHEIMERS-DISEASE INCREASES BETA-PROTEIN PRODUCTION [J].
CITRON, M ;
OLTERSDORF, T ;
HAASS, C ;
MCCONLOGUE, L ;
HUNG, AY ;
SEUBERT, P ;
VIGOPELFREY, C ;
LIEBERBURG, I ;
SELKOE, DJ .
NATURE, 1992, 360 (6405) :672-674